Primary Care Diabetes
Volume 3, Issue 3 , Pages 131-139, August 2009

Hypoglycaemia: An overview

Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, United Kingdom

Received 20 April 2009; received in revised form 17 August 2009; accepted 25 August 2009. published online 25 September 2009.

Abstract 

Hypoglycaemia is a frequent side-effect of treatment with insulin and sulfonylureas for people with diabetes, threatening potentially serious morbidity and preventing optimal glycaemic control. Fear of hypoglycaemia and development of syndromes such as impaired awareness and counterregulatory deficiency provide additional hazards for intensification of treatment. Rapid lowering of HbA1c may be potentially dangerous in type 2 diabetes because of the adverse cardiovascular effects induced by hypoglycaemia. Hypoglycaemia can disrupt many everyday activities such as driving, work performance and recreational pursuits. Measures to reduce the risk of hypoglycaemia are labour-intensive and require substantial resources.

Keywords: Diabetes, Hypoglycaemia, Impaired awareness of hypoglycaemia, Driving, Treatment of hypoglycaemia

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1751-9918(09)00087-4

doi:10.1016/j.pcd.2009.08.007

Primary Care Diabetes
Volume 3, Issue 3 , Pages 131-139, August 2009

Article Tools

* Image Usage & Resolution